Clinical Trial Update: Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing three anti-HIV regimens to prevent Nevirapine resistance in pregnant women taking Nevirapine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2012-01-19